DEC 20, 2016 11:42 AM PST

Congenital Herpes Infection Linked to Childhood Leukemia

WRITTEN BY: Xuan Pham

For the first time, researchers have traced a childhood form of blood cancer (acute lymphoblastic leukemia or ALL) to a specific virus. The virus, cytomegalovirus (CMV), is common in the herpes family. Children born with congenital infection of this virus have a high risk of developing ALL.

Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer, and involves the overproduction of immature white blood cells in the bone marrow. These cancerous cells invade the blood and other organ systems, causing massive cell death and damage in a short amount of time.

The causes of ALL vary from genetic abnormalities to exposure to DNA damaging agents. However, researchers have also suspected that infections by certain pathogens may also be a risk factor for developing ALL. To this end, researchers at the University of California, Berkeley and collaborators ventured to pinpoint a pathogen.

The team started by studying a group of 127 children with ALL and 38 children with AML - the myeloid version of leukemia. These children all had infections in their bone marrow in addition to the leukemia. A screen of these samples revealed that CMV infections were detected mostly from children with ALL.

The association was validated in a separate study involving blood samples from 268 newborns who developed ALL, and 270 healthy control newborns. They found a striking connection between presence of CMV and ALL diagnosis. Specifically, those who developed ALL were 3.81 times more likely to have also been diagnosed with congenital CMV.

"Our goal in tracking CMV back from the time of diagnosis to the womb was to establish that this infection occurred well before initiation of disease," said Stephen Francis, the study’s lead author.

Upon stratifying the link by ethnicity, the team found that Hispanic people seem to have the highest risk of developing ALL with CMV infection, at 5.9-fold increased risk.

CMV is a highly common virus. It’s estimated that nearly 80 percent of Americans have been infected with CMV. And most of these infections happen in childhood: one in 3 children are infected with CMV by 5 years of age. While the virus doesn’t usually cause illnesses, those with weakened immune systems may develop complications in vital organs. In particular, congenital CMV infections is typically associated with future hearing loss.

"If it's truly that in utero CMV is one of the initiating events in the development of childhood leukemia, then control of the virus has the potential to be a prevention target," Francis said. "That's the real take-home message."

"This is the first step, but if we do end up finding a causal link to the most common childhood cancer, we hope that will light a fire in terms of stopping mother-to-child transmission of CMV," said Francis .

Additional sources: American Society of Hematology

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 16, 2019
Cancer
NOV 16, 2019
Understanding H. pylori and gastric cancer
New research published in the journal Gastroenterology offers insight on gastric cancer and the presence of the common bacteria known as H. pylori (Helicob...
DEC 08, 2019
Cancer
DEC 08, 2019
Is there an association between smoking marijuana and cancer?
The controversy with marijuana is only likely to continue as research studies try to understand if marijuana use is associated to an increased risk of canc...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
JAN 02, 2020
Drug Discovery & Development
JAN 02, 2020
FDA Approves Ovarian Cancer Drug to Treat Pancreatic Cancer
In 2019, an estimated 46,000 Americans died from pancreatic cancer. Now, the Food and Drug Administration (FDA) has approved Lynparza, an ovarian cancer dr...
JAN 09, 2020
Drug Discovery & Development
JAN 09, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
Loading Comments...